X

Xenetic Biosciences
D

XBIO

4.30000
USD
0.38
(9.69%)
مغلق
حجم التداول
0
الربح لكل سهم
-2
العائد الربحي
-
P/E
-2
حجم السوق
6,631,198
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ALT
    -0.85500
    (-10.11%)
    7.60000 USD
    A
    AYTU
    -0.03000
    (-1.94%)
    1.52000 USD
    B
    BIOC
    -0.09610
    (-18.27%)
    0.42990 USD
    B
    BNGO
    -0.00920
    (-3.60%)
    0.24620 USD
    N
    NBRV
    0.04000
    (2.84%)
    1.45000 USD
    T
    TRVN
    -2.02000
    (-44.99%)
    2.47000 USD
    المزيد
الأخبار

العنوان: Xenetic Biosciences

القطاع: Healthcare
الصناعة: Biotechnology
Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing immune-oncology technologies addressing cancers. The company is also engaged in progressing XCART, a personalized CAR T platform technology. The Company's DNase platform is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which have been implicated in cancer progression and resistance to cancer treatments. The company also has oncology therapeutic investigational drug candidate XBIO-101 for the treatment of progestin-resistant endometrial cancer.